1.1 Relapse (as defined by study authors) |
11 |
|
Hazard Ratio (IV, Random, 95% CI) |
Subtotals only |
1.1.1 All studies |
11 |
1555 |
Hazard Ratio (IV, Random, 95% CI) |
1.97 [1.56, 2.50] |
1.1.2 No co‐intervention follow‐up > 24 weeks |
10 |
1373 |
Hazard Ratio (IV, Random, 95% CI) |
2.09 [1.59, 2.74] |
1.1.3 With co‐intervention follow‐up > 24 weeks |
2 |
182 |
Hazard Ratio (IV, Random, 95% CI) |
1.48 [0.93, 2.34] |
1.2 Adverse events |
7 |
1012 |
Odds Ratio (M‐H, Random, 95% CI) |
1.11 [0.62, 1.99] |
1.3 Depressive symptoms |
3 |
330 |
Mean Difference (IV, Random, 95% CI) |
0.44 [‐1.12, 2.00] |
1.3.1 HAM‐D total score endpoint |
1 |
140 |
Mean Difference (IV, Random, 95% CI) |
3.40 [0.42, 6.38] |
1.3.2 HAM‐D mean change |
2 |
190 |
Mean Difference (IV, Random, 95% CI) |
‐0.11 [‐1.54, 1.32] |
1.4 Severity of illness |
5 |
714 |
Mean Difference (IV, Random, 95% CI) |
0.31 [0.13, 0.49] |
1.4.1 CGI‐S total score |
2 |
343 |
Mean Difference (IV, Random, 95% CI) |
0.60 [0.27, 0.93] |
1.4.2 CGI‐S mean change |
3 |
371 |
Mean Difference (IV, Random, 95% CI) |
0.24 [0.05, 0.43] |